Biotech Company Chairman Suspected of $130M Loan Fraud; Management Executive Bailed for $500K
NQ Score
0/100
N1 Content Completeness
9
AI Summary (NQ-processed)
The chairman of a biotech company in Taiwan is under investigation for a massive fraud scheme, including fake capital increases, a $130M fraudulent bank loan, and illegal sales of unlisted stock totaling $400M. Prosecutors recently conducted a second wave of raids.